全文获取类型
收费全文 | 2302篇 |
免费 | 108篇 |
国内免费 | 301篇 |
出版年
2024年 | 4篇 |
2023年 | 59篇 |
2022年 | 102篇 |
2021年 | 80篇 |
2020年 | 66篇 |
2019年 | 99篇 |
2018年 | 60篇 |
2017年 | 58篇 |
2016年 | 53篇 |
2015年 | 87篇 |
2014年 | 108篇 |
2013年 | 138篇 |
2012年 | 85篇 |
2011年 | 131篇 |
2010年 | 98篇 |
2009年 | 146篇 |
2008年 | 135篇 |
2007年 | 132篇 |
2006年 | 158篇 |
2005年 | 136篇 |
2004年 | 113篇 |
2003年 | 101篇 |
2002年 | 86篇 |
2001年 | 73篇 |
2000年 | 66篇 |
1999年 | 59篇 |
1998年 | 39篇 |
1997年 | 48篇 |
1996年 | 34篇 |
1995年 | 23篇 |
1994年 | 26篇 |
1993年 | 24篇 |
1992年 | 23篇 |
1991年 | 20篇 |
1990年 | 7篇 |
1989年 | 6篇 |
1988年 | 4篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1983年 | 1篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 2篇 |
1974年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有2711条查询结果,搜索用时 15 毫秒
141.
The purpose of these studies was to enhance mucosal and systemic antibody production in response to increased local residence time of a whole inactivated influenza virus administered as a dry powder nasal vaccine formulation. Spray-freeze-drying (SFD) particles suitable for nasal delivery were characterized for physico-chemical properties and stability. Mucoadhesive compounds (MA) were characterized for their effects on nasal residence time of vaccine powders in rats compared with published in vitro data and elicited immune responses. SFD particles (D(50) = 26.9 microm) were spherical with a specific surface area of 1.25 m(2)/g. Thermal analysis indicated SFD powders were amorphous and demonstrated improved stability with respect to liquid formulations under various storage conditions. In vitro physico-chemical studies and in vivo scintigraphic imaging experiments indicated sodium alginate (SA) and carboxymethylcellulose-high molecular weight (CMC-HMW) powder formulations most significantly increased residence time in Brown Norway rats. Intramuscular delivery provided equivalent serum antibody titers to intranasal (IN) powder without MA, in the presence of CMC-HMW, SA, and hydroxypropyl methylcellulose (HPMC-HMW) after initial dosing and all formulations except IN powder with chitosan after boosting. IN liquid provided equivalent serum antibody titers to all IN powders after the initial vaccination and significantly greater serum antibody titers than IN powder with chitosan after boosting. Trends were consistent between residence time studies and immune response; however, no statistically significant differences between powder and liquid formulations were observed. It was concluded that enhanced serum and mucosal antibody responses were elicited by a dry powder nasal vaccine, specifically, administered in the presence of sodium alginate. 相似文献
142.
Michaela Šimčíková Kristala L. J. Prather Duarte M. F. Prazeres 《Biotechnology & genetic engineering reviews》2015,31(1-2):82-107
Despite very good safety records, clinical trials using plasmid DNA failed due to low transfection efficiency and brief transgene expression. Although this failure is both due to poor plasmid design and to inefficient delivery methods, here we will focus on the former. The DNA elements like CpG motifs, selection markers, origins of replication, cryptic eukaryotic signals or nuclease-susceptible regions and inverted repeats showed detrimental effects on plasmids’ performance as biopharmaceuticals. On the other hand, careful selection of promoter, polyadenylation signal, codon optimization and/or insertion of introns or nuclear-targeting sequences for therapeutic protein expression can enhance the clinical efficacy. Minimal vectors, which are devoid of the bacterial backbone and consist exclusively of the eukaryotic expression cassette, demonstrate better performance in terms of expression levels, bioavailability, transfection rates and increased therapeutic effects. Although the results are promising, minimal vectors have not taken over the conventional plasmids in clinical trials due to challenging manufacturing issues. 相似文献
143.
Periela da Silva Sousa-Vasconcelos Wellington da Silva Seguins Eduardo de Souza Luz Rosa Teixeira de Pinho 《Memórias do Instituto Oswaldo Cruz》2015,110(6):809-813
Tuberculosis has great public health impact with high rates of mortality and the only
prophylactic measure for it is the Mycobacterium bovisbacillus
Calmette-Guérin (BCG) vaccine. The present study evaluated the release of cytokines
[interleukin (IL)-1, tumour necrosis factor and IL-6] and chemokines [macrophage
inflammatory protein (MIP)-1α and MIP-1β] by THP-1 derived
macrophages infected with BCG vaccine obtained by growing mycobacteria in Viscondessa
de Moraes Institute medium medium (oral) or Sauton medium (intradermic) to compare
the effects of live and heat-killed (HK) mycobacteria. Because BCG has been reported
to lose viability during the lyophilisation process and during storage, we examined
whether exposing BCG to different temperatures also triggers differences in the
expression of some important cytokines and chemokines of the immune response.
Interestingly, we observed that HK mycobacteria stimulated cytokine and chemokine
production in a different pattern from that observed with live mycobacteria. 相似文献
144.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II,open‐label,uncontrolled trial in Japan 下载免费PDF全文
Yukari Tsurudome Kazuhiko Kimachi Yusuke Okada Kenta Matsuura Yusuke Ooyama Kayo Ibaragi Yoichiro Kino Kohji Ueda 《Microbiology and immunology》2015,59(10):597-604
Two antigenically distinct B strain lineages of influenza virus have co‐circulated since the mid‐1980s; however, inactivated trivalent influenza vaccines contain only one B lineage. The mismatch between the circulating and vaccine lineages has been a worldwide issue. In this study, an inactivated quadrivalent influenza vaccine (QIV) candidate containing two B lineages was manufactured and its immunogenicity and safety evaluated in an open‐label, uncontrolled trial. In this phase II trial, 50 subjects aged 20–64 years received two doses of QIV s.c. 1 to 4 weeks apart. Sera were collected pre‐ and post‐vaccination and safety assessed from the first vaccination to 21 ± 7 days after the second vaccination. After the first vaccination, hemagglutination inhibition titers against each strain increased markedly; the seroconversion rate, geometric mean titer ratio and seroprotection rate being 94.0%, 24.93, and 100.0%, respectively, for the A/H1N1pdm09 strain; 94.0%, 12.47, and 98.0%, respectively, for the A/H3N2 strain; 54.0%, 4.99, and 66.0%, respectively, for B/Yamagata strain, and 72.0%, 6.23 and 80.0%, respectively, for the B/Victoria strain, thus fulfilling the criteria of the European Medical Agency's Committee for Medicinal Products for Human Use. Also, the QIV induced sufficient single radial hemolysis and neutralizing antibodies against all four vaccine strains. No noteworthy adverse events were noted. The results of this trial demonstrate that QIV is well tolerated and immunogenic for each strain, suggesting that QIV potentially improves protection against influenza B by resolving the issue of B lineage mismatch. 相似文献
145.
Successful selection of an infection‐protective anti‐Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models 下载免费PDF全文
Hiroyoshi Ohsawa Tadashi Baba Jumpei Enami Keiichi Hiramatsu 《Microbiology and immunology》2015,59(4):183-192
Recent clinical trials to develop anti‐methicillin‐resistant Staphylococcus aureus (MRSA) therapeutic antibodies have met unsuccessful sequels. To develop more effective antibodies against MRSA infection, a panel of mAbs against S. aureus cell wall was generated and then screened for the most protective mAb in mouse infection models. Twenty‐two anti‐S. aureus IgG mAbs were obtained from mice that had been immunized with alkali‐processed, deacetylated cell walls of S. aureus. One of these mAbs, ZBIA5H, exhibited life‐saving effects in mouse models of sepsis caused by community‐acquired MRSA strain MW2 and vancomycin‐resistant S. aureus strain VRS1. It also had a curative effect in a MW2‐caused pneumonia model. Curiously, the target of ZBIA5H was considered to be a conformational epitope of either the 1,4‐β‐linkage between N‐acetylmuramic acid and N‐acetyl‐D‐glucosamine or the peptidoglycan per se. Reactivity of ZBIA5H to S. aureus whole cells or purified peptidoglycan was weaker than that of most of the other mAbs generated in this study. However, the latter mAbs did not have the protective activities against S. aureus that ZBIA5H did. These data indicate that the epitopes that trigger production of high‐yield and/or high‐affinity antibodies may not be the most suitable epitopes for developing anti‐infective antibodies. ZBIA5H or its humanized form may find a future clinical application, and its target epitope may be used for the production of vaccines against S. aureus infection. 相似文献
146.
Nicholas C. Grassly Gagandeep Kang Beate Kampmann 《Philosophical transactions of the Royal Society of London. Series B, Biological sciences》2015,370(1671)
The reason for holding a meeting to discuss biological challenges to vaccines is simple: not all vaccines work equally well in all settings. This special issue reviews the performance of vaccines in challenging environments, summarizes current thinking on the reasons why vaccines underperform and considers what approaches are necessary to understand the heterogeneity in responses and to improve vaccine immunogenicity and efficacy. 相似文献
147.
Initial design and physical characterization of a polymeric device for osmosis‐driven delayed burst delivery of vaccines 下载免费PDF全文
148.
利用细菌人工染色体技术将串联的HIV-1 gp160、gag和protease基因以及表达元件插入1型单纯疱疹病毒(Herpes simplex virus type 1,HSV-1)内部反向重复序列区,以获得携带HIV-1抗原的单纯疱疹病毒载体疫苗。首先将HIV-1 gp160(B型和C型)、gag和protease基因串联克隆入pc DNA3获得重组质粒pc DNA/g Bgp和pc DNA/g Cgp,重组质粒转染293FT细胞,Western blotting检测HIV抗原表达。继而将pc DNA/g Bgp和pc DNA/g Cgp中包括HIV-1抗原基因和表达元件的表达框克隆入p KO5/BN获得重组穿梭质粒p KO5/BN/g Bgp和p KO5/BN/g Cgp,穿梭质粒电转含BAC-HSV的大肠杆菌,筛选重组菌,提取重组DNA并转染Vero细胞,挑取病毒蚀斑纯化重组病毒,Southern blotting鉴定重组病毒DNA,Western blotting检测重组病毒感染细胞中HIV抗原表达,并分析病毒的增殖特性。结果表明,Western blotting在pc DNA/g Bgp和pc DNA/g Cgp转染的293FT细胞中检测到表达的gp160和gag蛋白。p KO5/BN/g Bgp和p KO5/BN/g Cgp分别电转获得重组菌,并从重组DNA转染的Vero细胞中纯化获得重组HSV,Southern blotting检测表明重组HSV基因组发生特异性重组,重组病毒感染细胞中检测到gp120和gp41,且重组HSV保留了在哺乳动物细胞中的复制能力。本研究获得携载HIV-1 gp160、gag和protease基因的重组HSV,并保留了在哺乳动物细胞中的复制能力,可作为HIV-1复制型病毒载体疫苗。 相似文献
149.
抗肿瘤多肽具有分子质量小、特异性高、免疫原性低、生物利用度高等优点,且易于合成和改造,其在肿瘤治疗领域的应用研究近
年来受到广泛关注。目前,已有多种抗肿瘤多肽及其衍生物上市或进入临床研究,对于肿瘤的临床治疗具有重要价值。综述抗肿瘤多肽在
诱导肿瘤细胞凋亡、抑制肿瘤新生血管生成、抑制肿瘤细胞生长和转移以及用作疫苗和药物载体等方面的研究新进展。 相似文献
150.
Yi-Ting Huang Jia-Teh Liao Li-Chen Yen Yung-Kun Chang Yi-Ling Lin Ching-Len Liao 《Journal of biomedical science》2015,22(1)